Last Updated on February 27, 2022 by The Health Master
Lucknow The Council of Scientific and Industrial Research- Central Drug Research Institute (CSIR-CDRI), along with the ICMR (Indian Council of Medical Research), will begin phase-III clinical trials for the Picroliv drug for treatment of fatty liver.
A phytopharmaceutical product, Picroliv, developed by the CDRI, has got the nod for phase-III clinical trial for the treatment of fatty liver disease, according to a press release issued by the CDRI.
Picroliv has been developed from the plant picrorhiza kurroa, also known as Kutki.
CDRI Director, Dr D. Srinivas Reddy, informed us that CDRI received permission for a phase-III clinical trial of the drug in patients of non-alcoholic fatty liver disease (NAFLD). The new drug may reduce the fat in the liver and its subsequent complications.
The trial will be conducted in six hospitals, including AIIMS Delhi, ILBS Delhi, PGIMER Chandigarh, KEM Mumbai, NIMS Hyderabad and KGMU Lucknow in collaboration with the ICMR.
Non-alcoholic fatty liver disease (NAFLD) refers to accumulation of excess fat in the liver of people who consume little or no alcohol.
NAFLD is the most prevalent liver disease in human history, with prevalence estimates indicating it affects almost two billion people globally. In India it is estimated to affect nearly 25-30% of the general population.
Dr Vivek Bhosale, medical expert of CSIR-CDRI, informed us that it was a common condition in obese individuals or people with diabetes.
Usually, there are no symptoms. There may, however, be some amount of abdominal pain that may be concentrated in the central or right upper part of the abdomen. Fatigue and tiredness may be additional symptoms.
The liver may be enlarged in some cases. An ultrasound of the abdomen, however, can show the fatty deposits over the liver and confirm the diagnosis.
USFDA gives nod to Zydus to market Dapagliflozin tablets
CDSCO gives nod to Cipla to conduct study on Paxlovid
IPA to organise 7th Global Pharmaceutical Quality Summit
BIS sets standard for these Medical Devices
The mandatory QR codes on APIs
NPPA fixes retail price of 19 formulations: February 2022
ICMR to conduct Clinical Trial for new drugs regimen for MDR TB
PCB issues directions to Pharma Companies to comply with norms
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
